Cargando…

Tongue as a first-line immune organ?

Detalles Bibliográficos
Autor principal:	Wu, Jane Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Higher Education Press 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796681/ https://www.ncbi.nlm.nih.gov/pubmed/33420957 http://dx.doi.org/10.1007/s13238-020-00802-x

Ejemplares similares

Mother tongue? Muttersprache? Lingua mater? Not so fast!
por: Graur, Dan
Publicado: (2019)

First-line immune-chemotherapy combination for squamous NSCLC is already a reality
por: Hendriks, Lizza E. L., et al.
Publicado: (2020)

Increasing Options for First-Line Therapy in Primary FSGS?
por: Lafayette, Richard A.
Publicado: (2018)

Tebentafusp in first-line melanoma trials: An outperforming outlier
por: Olivier, Timothée, et al.
Publicado: (2022)

Efficacy of first-line immunization combined with antiangiogenesis treatment and chemotherapy for the treatment of tongue cancer: A case report
por: Zhao, Limin, et al.
Publicado: (2023)

Immune-checkpoint inhibitors plus chemotherapy versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer
por: Zhou, Fei, et al.
Publicado: (2020)

Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor
por: Ornstein, Moshe C., et al.
Publicado: (2023)

Repair cell first, then regenerate the tissues and organs
por: Fu, Xiao-Bing
Publicado: (2021)

Should radioiodine now be first line treatment for Graves’ disease?
por: Okosieme, Onyebuchi E., et al.
Publicado: (2020)

First-line immune checkpoint inhibitors for patients with metastatic urothelial carcinoma treated in routine clinical practice
por: Naito, Renato, et al.
Publicado: (2020)

The first step in utilizing immune-modulating therapies: immune status determination
por: Caldwell, Charles C, et al.
Publicado: (2011)

Lung ultrasound must be the first-line image technique in COVID-19 patients
por: Torres-Macho, Juan, et al.
Publicado: (2023)

Walking the Line Between Antidonor and Antiviral Immunity: A Potential Role for Belatacept
por: Gunasekaran, Deepthi, et al.
Publicado: (2022)

Understanding the role of the R-spondin 2-LGR4 system in tongue squamous cell carcinoma progression
por: Al-Samadi, Ahmed, et al.
Publicado: (2019)

Transition to ultrasound as the first-line imaging modality for midgut volvulus: keys to a successful roll-out
por: Nguyen, HaiThuy N., et al.
Publicado: (2021)

Will whole-genome sequencing become the first-line genetic analysis for male infertility in the near future?
por: Ghieh, Farah, et al.
Publicado: (2021)

Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain Metastasis
por: Liu, Geoffrey, et al.
Publicado: (2023)

First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely
por: Ivanyi, Philipp, et al.
Publicado: (2023)

Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer
por: Arteaga, Carlos L
Publicado: (2003)

CheckMate 227 trial has not checked the immune-strategy in first-line setting in advanced non-small cell lung cancer
por: Remon, Jordi, et al.
Publicado: (2020)

Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization–Recommended Weight Band Doses and Formulations
por: Chabala, Chishala, et al.
Publicado: (2021)

A team effort: natural killer cells on the first leg of the tumor immunity relay race
por: Fessenden, Timothy B., et al.
Publicado: (2018)

Cancer of Tongue.—Removal of Entire Organ
por: Roddick,
Publicado: (1882)

Progression after discontinuation of bevacizumab in the first-line treatment of ovarian cancer
por: Nakai, Hidekatsu, et al.
Publicado: (2023)

First Publication of Standardized Immune Monitoring Methods From the Virtual Global Transplantation Laboratory Initiative
por: Geissler, Edward K.
Publicado: (2016)

Lenvatinib in elderly hepatocellular carcinoma patients, a new therapeutic option in first line
por: Roth, Gael S., et al.
Publicado: (2020)

New first-line treatment strategies for advanced lung squamous cell carcinoma
por: Cai, Xiuyu, et al.
Publicado: (2020)

PARP inhibitors, use early in the first-line maintenance therapy setting but with caution
por: Giudice, Elena, et al.
Publicado: (2023)

Cell line authentication: a necessity for reproducible biomedical research
por: Souren, Nicole Y, et al.
Publicado: (2022)

Preparing for the next pandemic by creating Canadian Immunization Services
por: Wilson, Kumanan, et al.
Publicado: (2021)

The immune cell transcription factor T-bet: A novel metabolic regulator
por: Stolarczyk, Emilie, et al.
Publicado: (2014)

Cost-effectiveness of Osimertinib in activating epidermal growth factor receptor gene (EGFR)-mutations in first-line for advanced non-small cell lung cancer
por: Giuliani, Jacopo, et al.
Publicado: (2021)

First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy
por: Zhou, Yixin, et al.
Publicado: (2019)

The Very First Changes in the Tongue with the Development of Cancer
por: Hamada, Kenta, et al.
Publicado: (2017)

Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness
por: Martin, Thomas R., et al.
Publicado: (2020)

Organ donation after circulatory death: the forgotten donor?
por: Rady, Mohamed Y, et al.
Publicado: (2006)

Replication timing kept in LINE
por: O’Neill, Rachel J., et al.
Publicado: (2018)

Embracing Telemedicine: The Silver Lining of a Pandemic
por: Guido-Estrada, Natalie, et al.
Publicado: (2020)

PD-1/PD-L1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in first-line treatment for non-squamous non-small-cell lung cancer
por: Yu, Hui, et al.
Publicado: (2021)

First-line pembrolizumab in programmed death ligand 1 positive non-small cell lung cancer
por: Travert, Camille, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_99hre4eiuvvs64a40htbjj85g8